Trade Analytics

GSK India

Go Back

GSK India

  • More than eight decades of operation in India
  • One of India’s oldest pharmaceuticals company
  • Global leader in biotechnology sector
  • Employs over 4500 people

Established in the year 1924 in India, GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company and employs over 4500 people. Globally, the company is a £ 26.5 billion (US$ 41.28 billion), leading, research-based healthcare and pharmaceutical company.

The GSK India product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases. The company is the market leader in most of the therapeutic categories in which it operates. GSK also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others.


GSK India: Leading Indian Biotechnology Company

2014 Gets named as one of 'India's Most Admired Companies' by Fortune India in partnership with the Hays Group
2012 Receives the Paediatrician's Award for the Best Vaccine Company of the Year by Frost & Sullivan
2011 Unveils Synflorix - a vaccine against invasive pneumococcal disease
2010 Launches Mycamine, an injectible antifungal drug in-licensed from Astellas, Japan
2009 Commences Albendazole production in Nashik to treat Lymphatic Filariasis

Updated: December, 2014

India is ranked 12th in the world in biotech and third in Asia-Pacific.